Joint Statement on Intravesical Administration of Therapeutic Medication

SUNA and the American Urological Association (AUA) developed a joint Statement of Practice on Intravesical Administration of Therapeutic Medication. The purpose of the statement is to define the performance guidelines surrounding the instillation of intravesical cytotoxic, immunotherapeutic, and/or therapeutic drugs via sterile technique catheterization for patients with non-muscle invasive bladder cancer (urothelial carcinoma) or interstitial cystitis/bladder pain syndrome.

Download the Statement

Intravesical Instillation with Mitomycin C or Bacillus Calmette-Guérin in Non-Muscle Invasive Bladder Cancer

The European Association of Urology Nurses (EAUN) released a new Evidence-Based Guideline for Best Practice in Urological Healthcare at the 16th International EAUN Meeting in Madrid in March 2015. The guideline is entitled Intravesical Instillation with Mitomycin C or Bacillus Calmette-Guérin in Non-Muscle Invasive Bladder Cancer. Access the guideline at the link below.

Download the Guideline

Pages